From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer
No. of Regimens per Patient
No. of Patients
Percentage (%)
Any Regimen
2
6
30
3
5
25
4
15
10
>5
20
Platinum-Based Combination Chemotherapy
1
8
40
0